Senior Scientist / Lead is open at Ohalo in South San Francisco. The posting gives a salary of $155K - $170K. Posted on Nov 16, 2026, and still on Ohalo’s careers page when we last checked, on Nov 17, 2026.
About the role
Position Title: Senior Scientist / Lead, Plant Transformation & Genome Editing Delivery
Location: South San Francisco, CA (Onsite)
Time Type: Full Time
Reports To: Science R&D Leadership
About Ohalo
Ohalo is using an evolutionary lens to reimagine the art and science of plant breeding. Our Boosted Breeding™ technology changes how genetic diversity is created and combined, and we are applying it across major crops to transform breeding and production systems with the goal of sustainably supporting the world's growing population. We are headquartered in the San Francisco Bay Area with breeding, laboratory, and field operations across the United States.
The Opportunity
Ohalo is seeking a Senior Scientist and Technical Lead to stand up, scale, and innovate our in-house cereal and monocot transformation and genome-editing delivery platform at our South San Francisco research facility. Every construct and multiplex genome-editing hypothesis in our reproductive biology and trait discovery programs depends on turning plasmid, donor template, and ribonucleoprotein (RNP) designs into fertile, well-characterized T0 and E0 plants on a predictable clock across Agrobacterium, biolistic, protoplast, and emerging cellular delivery modalities.
This role combines two jobs that usually sit apart in agricultural biotech:
- Pipeline architecture and production execution. Stand up a continuous construct-to-T0/E0 pipeline in model and reference cereal lines at 50 to 100+ constructs and editing designs per year. You own the end-to-end system across Agrobacterium-mediated, biolistic, and DNA-free/RNP delivery routes: staggered weekly donor-plant cohorts in controlled-environment chambers, aseptic explant and protoplast isolation, cargo delivery and co-cultivation/transfection, resting and dual-stage selection, shoot/root regeneration, and greenhouse handoff, with published metrics for transformation and editing efficiency, low-copy or DNA-free event rate, and turnaround time (targeting 10 to 13 weeks from delivery to T0/E0 plantlets).
- Delivery modality R&D, editing systems, and genotype independence. Push transformation and genome editing beyond permissive laboratory check cultivars into recalcitrant elite spring and winter breeding germplasm. You will design and run quantitative Design of Experiments (DOE) campaigns testing morphogenic regulators (e.g., GRF-GIF chimeras, WOX5, BBM/WUS2), local wound-regeneration peptides (e.g., REF1), ternary/auxotrophic Agrobacterium helper systems, biolistic particle bombardment, protoplast/RNP transfection, meristem or in-planta delivery, and multiplex CRISPR/Cas nuclease, base-editing, prime-editing, cisgenic, and marker-free excision architectures that preserve freedom to operate.
You will work at the bench to establish and validate new protocols yourself, while leading and mentoring a team of 1 to 3 Research Associates and technicians in our dedicated South San Francisco transgenic containment suite. At Ohalo, scientists operate as AI-native builders: you will use agentic AI tools (e.g., Claude Code) every day alongside wet-lab execution to design factorial experiments, synthesize literature and patent landscapes, compile executable SOPs, and analyze stage-by-stage conversion data directly from our internal data platform.
Responsibilities
Pipeline Architecture and Production
- Stand up and own the end-to-end cereal transformation and genome-editing delivery pipeline in South San Francisco across Agrobacterium, biolistic, and RNP/protoplast modalities, from weekly donor-plant planting schedules and vernalization/growth-chamber recipes (12 to 14 days post-anthesis immature embryo and donor tissue supply) through T0/E0 plantlet acclimatization and T1/E1 seed harvest.
- Establish, version, and enforce Standard Operating Procedures (SOPs) for explant micro-dissection and protoplast isolation, physical and chemical pre-treatments (centrifugation, embryonic axis excision, osmotic conditioning, surfactant/PEG delivery), Agrobacterium co-cultivation and biolistic bombardment, callus induction, resting, selection (hygromycin, bialaphos/glufosinate, mannose, or marker-free sorting), and regeneration.
- Manage capacity, queue prioritization, and turnaround SLAs across 50 to 100+ annual construct and multiplex-editing runs, balancing steady-state production against milestone-driven R&D campaigns.
- Coordinate with external domestic transformation CROs as needed to manage overflow capacity, benchmark internal efficiency, and transition outsourced protocols in-house.
Delivery Modality R&D, Editing Systems, and Genotype Independence
- Develop and optimize genotype-flexible transformation protocols that transfer cleanly from permissive reference cultivars into commercial spring and winter cereal lines across multiple market classes.
- Design statistically powered factorial and Bayesian DOE trials to evaluate regeneration boosters (developmental transcription factors, chimeric regulators, wound-signaling peptides), media formulations (auxin/cytokinin ratios, copper/silver ions, osmoticum), Agrobacterium strain/ternary vector combinations (e.g., EHA105, AGL1, LBA4404, auxotrophic strains, vir-helper plasmids), biolistic microcarrier/rupture-disk parameters, and RNP/mRNA/plasmid cellular delivery conditions.
- Develop and validate broad genome-editing and cargo-delivery workflows—including multiplex CRISPR/Cas nucleases, base editors, prime editors, homology-directed or prime-mediated knock-in, cisgenic/intragenic delivery, and marker-free or Cre/lox excision—matching each editing cargo to the optimal delivery system (Agrobacterium, biolistic bombardment, protoplast/RNP transfection, or meristem/in-planta routes).
- Evaluate freedom-to-operate (FTO) constraints across vector backbones, selectable markers, and regeneration boosters in partnership with Science Leadership and IP counsel, designing unencumbered internal protocols.
AI-Native Scientific Workflows, Data Capture, and Molecular Handoff
- Partner with our South San Francisco Genotyping and Automation teams on high-throughput 96-well tissue and cell sampling, magnetic-bead DNA extraction, subgenome-specific amplicon sequencing, and ddPCR copy-number assays to verify single-copy insertions, backbone- and plasmid-free DNA-free edits, HDR/knock-in precision, and multi-homeolog biallelic edits at the cellular and T0/E0 stages.
- Enforce in-situ digital data capture in Ohalo's internal breeding and lab platform (Plantorium): record every donor plant, explant batch, media lot, inoculation treatment, passage step, contamination rate, and regenerated putative event at the bench in real time rather than transcribing from paper or spreadsheets.
- Operate as an AI-native scientist: use agentic AI and computational tools (e.g., Claude Code, Python/R, internal DOE, power-simulation, and literature/patent analysis workflows) daily to design experiments, compile executable protocols, analyze stage-by-stage conversion rates, and diagnose variance across donor cohorts, operators, and incubator shelves.
Team Leadership and Biosafety
- Recruit, train, and lead 1 to 3 Research Associates and transformation technicians; build an operator qualification program (Novice to Autonomous to Instructor) covering aseptic micro-dissection, media preparation, and stage scoring.
- Maintain strict physical and operational containment between regulated transgenic/Agrobacterium workflows and DNA-free editing rooms in the South San Francisco facility, ensuring full compliance with USDA-APHIS BRS permits, autoclave/inactivation SOPs, and environmental swabbing controls.
Requirements
- Ph.D. in Plant Biology, Plant Biotechnology, Cellular & Molecular Biology, Agronomy, or a related field with 3 to 6+ years of post-doctoral or industry experience (or M.S. with 7+ years of industry experience) leading cereal or monocot transformation and genome-editing delivery.
- Proven, hands-on mastery of cereal/monocot transformation, cellular delivery, and tissue-culture regeneration in recalcitrant crops (e.g., wheat, maize, barley, sorghum, or rice) across one or more core delivery modalities (Agrobacterium-mediated, biolistic particle bombardment, or protoplast/RNP systems), with a documented track record of generating fertile, low-copy T0 or edited E0 plants at high efficiency.
- Deep technical fluency in monocot regeneration biology, including morphogenic regulators (e.g., GRF4-GIF1, WOX5, BBM/WUS2), ternary vector and super-binary helper systems, selectable marker systems, and somatic embryogenesis troubleshooting.
- Hands-on expertise delivering diverse genome-editing systems in diploid and polyploid cereals—including multiplex CRISPR/Cas nucleases, base editors, prime editors, tRNA-gRNA or array architectures, and donor knock-in / cisgenic templates—and interpreting molecular event-quality data (ddPCR copy number, plasmid/backbone absence, junction/amplicon NGS).
- Breadth across multiple plant delivery systems—combining Agrobacterium binary/ternary vectors, biolistic bombardment, DNA-free RNP/protoplast transfection, or meristem/embryo/in-planta delivery—and ability to select and optimize the right modality for transgenic, cisgenic, and non-transgenic editing applications.
- Demonstrated experience training and supervising Research Associates or technicians in a high-throughput tissue-culture or transformation core, with a focus on quantitative KPIs (conversion rate per embryo, contamination rate, low-copy yield, cost per construct).
- Demonstrated daily use of modern AI and LLM/agentic tools in scientific workflows (e.g., experimental design, literature and patent synthesis, protocol drafting, code-assisted data analysis, or troubleshooting), paired with a rigorous approach to experimental design (randomization, blocking, biological replication, statistical power) and real-time LIMS/database capture.
Preferred Qualifications
- Direct experience establishing a new cereal transformation pipeline or facility from commissioning to steady-state production, including Conviron/growth-chamber donor-plant optimization and vernalization management.
- Experience transforming polyploid cereals and overcoming subgenome redundancy or cultivar recalcitrance across diverse spring and winter germplasm.
- Experience with excisable morphogenic cassettes (Cre/lox, developmentally regulated promoters), wound-signaling peptides, or alternative explants (mature embryos, meristems, spike/in-planta methods).
- Familiarity with intellectual property and freedom-to-operate considerations in monocot transformation protocols (e.g., binary vs. super-binary vectors, morphogenic gene licensing, selectable markers).
- Hands-on experience with agentic coding and analysis environments (e.g., Claude Code, Cursor, Jupyter/Python/R) to automate data pipelines, build statistical or Bayesian DOE models, and query laboratory databases directly.
The anticipated base pay range for this role is $155,000 - $170,000 per year for our South San Francisco, CA location, with flexibility above this range for an exceptional candidate. The pay offered to a selected candidate will be determined based on factors such as (but not limited to) the scope and responsibilities of the position, the qualifications of the selected candidate, budget availability, internal equity, geographic location, and external market pay for comparable jobs.
The employer’s own description, as published on Ohalo’s careers page.
Hiring at Ohalo
Ohalo has 20 open roles right now, 3 of them remote. Most are in Sales & Business Development, Operations and Manufacturing & Trades. See all its roles
✓ Actively hiring 3 roles posted in the last 7 days✓ States the pay 70% of its open roles state itWhat the marks mean
